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Introduction
Protein identification is a main problem in proteomics,
the large-scale analysis of proteins. Tandem mass spec-
trometry (MS/MS) provides an important tool to handle
protein identification problem. Indeed the spectrometer
is capable of ionizing a mixture of peptides, essentially
several copies of the same unknown peptide, dissociating
every molecule into two fragments called complementary
ions, and measuring the mass/charge ratios of the pep-
tides and of their fragments. These measures are visualized
as mass peaks in a mass spectrum.
There are two fundamental approaches to interpret the
spectra. The first approach is to search in a database to
find the peptides that match the MS/MS spectra. This data-
base search approach is effective for known proteins, but
does not permit to detect novel proteins. This second task
can be dealt with the de novo sequencing that computes
the amino acid sequence of the peptides directly from
their MS/MS spectra.
In the de novo sequencing problem one knows the pep-
tide mass mP, and a subset of the masses of its ions
m1,...,mn, and the task is to determine a sequence Q of
masses of residues such that subsets of its prefixes and suf-
fixes give the masses in input. The solution is, in general,
not unique.
Methods
We reformulate the problem in terms of searching paths
in a graph. To this goal, let MP denote the set of ion masses
mi in input increased with: their complementary masses
mP - mi + 2, the mass of the hydrogen, 1, and of its comple-
mentary mass mP - 17. By abuse of notation, MP =
{m1,...,mn}, where mi <mj if i <j.
We build a directed acyclic graph GP = (V, E) as follows.
Let a node vi associate to a member mi of MP, and an edge
from vi to vj if mj - mi equals the sum of residue masses.
The de novo sequencing problem consists in determining
any path from v1 to vn in the graph GP.
Although there is a unique original protein, the de novo
sequencing may have in general more solutions (or
none). In order to choose one sequence among the possi-
ble solutions, researchers have introduced any scoring
function [1-3] depending on the masses of the fragments
in the spectra. Our algorithm can determine either the
solution of maximum score according to any given func-
tion or that of maximum length.
We use 3 algorithms:
 the first algorithm consists in building the graph;
 the second algorithm permits to distinguish the feasible
paths that start in v1 and terminate in vn among the others;
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 finally, the third algorithm retrieves the solution of max-
imum score.
Results and conclusion
The literature offers a wide range of sequential de novo
sequencing algorithm, all taking O(n logn) time, at least
[4,5]. Aiming at lowering such time barrier, we proposed
a work-efficient CREW (concurrent-read exclusive write)
PRAM [6] algorithm for the de novo peptide sequencing
that determines the maximum length sequence in O(n)
time by using log n processors. Such theoretical result
showed that our algorithm is clearly scalable and reaches
the theoretical, ideal efficiency.
The next step we are working on is the implementation of
the proposed algorithm on a parallel machine to verify
such theoretical results and scalability features.
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